94 related articles for article (PubMed ID: 31609098)
1. Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: A population-based study.
Zheng Z; Chen C; Jiang L; Zhou X; Dai X; Song Y; Li Y
Cancer Med; 2019 Dec; 8(17):7288-7298. PubMed ID: 31609098
[TBL] [Abstract][Full Text] [Related]
2. Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population-based analysis.
Wang J; Li S; Liu Y; Zhang C; Li H; Lai B
Cancer Med; 2020 Jan; 9(1):361-373. PubMed ID: 31693304
[TBL] [Abstract][Full Text] [Related]
3. Analyses of sex-based clinicopathological differences among patients with gastrointestinal neuroendocrine neoplasms in Europe.
Jann H; Krieg S; Krieg A; Eschrich J; Luedde T; Kostev K; Loosen S; Roderburg C
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7557-7563. PubMed ID: 36971798
[TBL] [Abstract][Full Text] [Related]
4. Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data.
Davis FG; Dolecek TA; McCarthy BJ; Villano JL
Neuro Oncol; 2012 Sep; 14(9):1171-7. PubMed ID: 22898372
[TBL] [Abstract][Full Text] [Related]
5. Distinct characteristics of distant metastasis in early-onset gastric cancer patients compared to late-onset patients: An observational study.
Wu F; Wu S; Shuai S
Medicine (Baltimore); 2024 May; 103(20):e38098. PubMed ID: 38758891
[TBL] [Abstract][Full Text] [Related]
6. Alteration of the immunophenotype and cytokine profiles in patients affected by neuroendocrine neoplasms.
Boemi I; Piccini S; Colombo FS; Smiroldo V; Zerbi A; Capretti G; Alloisio M; Trivellin G; Lavezzi E; Mazziotti G; Vitali E; Lania AG
Endocrine; 2024 Mar; 83(3):810-823. PubMed ID: 37845576
[TBL] [Abstract][Full Text] [Related]
7. The crucial role of age and site in incidence and prognosis of female neuroendocrine neoplasms in the United States: a population-based study from 2000 to 2018.
Xiao G; Xu Z; Zhang Y; Dai S; Ouyang G; Huang Y; Liu Y; Cao D; Luo F
Aging (Albany NY); 2024 Mar; 16(5):4204-4223. PubMed ID: 38431305
[TBL] [Abstract][Full Text] [Related]
8. Adrenal tumors in patients with neuroendocrine neoplasms.
Falhammar H; Stenman A; Juhlin CC; Kistner A
Endocrine; 2024 Apr; ():. PubMed ID: 38581593
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for pancreas and lung neuroendocrine neoplasms: a case-control study.
Giraldi L; Vecchioni A; Carioli G; Bilotta M; La Rosa S; Imperatori A; Volante M; Brizzi MP; Inzani F; Petrone G; Schinzari G; Bianchi A; Margaritora S; Alfieri S; La Vecchia C; Boccia S; Rindi G
Endocrine; 2021 Jan; 71(1):233-241. PubMed ID: 32869113
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Design, Eligibility, and Outcomes of Neuroendocrine Neoplasm Trials Initiated From 2000 to 2009 vs 2010 to 2020.
Das S; Du L; Lee CL; Arhin ND; Chan JA; Kohn EC; Halperin DM; Berlin J; LaFerriere H; Singh S; Kunz PL; Dasari A
JAMA Netw Open; 2021 Oct; 4(10):e2131744. PubMed ID: 34705010
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of brain metastases and leptomeningeal disease.
Lamba N; Wen PY; Aizer AA
Neuro Oncol; 2021 Sep; 23(9):1447-1456. PubMed ID: 33908612
[TBL] [Abstract][Full Text] [Related]
12. Leukemia in gastrointestinal organs as cause of treatment failure: 378 cases analyzed.
Cunningham I; Worthley D
Am J Hematol; 2018 Nov; 93(11):1327-1336. PubMed ID: 30105897
[TBL] [Abstract][Full Text] [Related]
13. Imaging of Neuroendocrine Neoplasms; Principles of Treatment Strategies. What Referring Clinicians Want to Know.
Asmundo L; Ambrosini V; Mojtahed A; Fanti S; Ferrone C; Hesami M; Sertic M; Najmi Z; Furtado FS; Dhami RS; Anderson MA; Samir A; Sharma A; Campana D; Ursprung S; Nikolau K; Domachevsky L; Blake MA; Norris EC; Clark JW; Catalano OA
J Comput Assist Tomogr; 2024 Apr; ():. PubMed ID: 38626751
[TBL] [Abstract][Full Text] [Related]
14. Pattern and prognosis of distant metastases in nasopharyngeal carcinoma: A large-population retrospective analysis.
Qu W; Li S; Zhang M; Qiao Q
Cancer Med; 2020 Sep; 9(17):6147-6158. PubMed ID: 32649056
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Homogeneous and Heterogeneous Factors for Bone Metastasis in Esophageal Cancer.
Zhang J; Ma W; Wu H; Wang J; Lin Y; Wang X; Zhang C
Med Sci Monit; 2019 Dec; 25():9416-9425. PubMed ID: 31821313
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics and survival outcomes in breast carcinosarcoma: A SEER population-based study.
Lin S; Liu C; Tao Z; Zhang J; Hu X
Breast; 2020 Feb; 49():157-164. PubMed ID: 31812891
[TBL] [Abstract][Full Text] [Related]
17. Treatment of advanced gallbladder cancer: A SEER-based study.
Mao W; Deng F; Wang D; Gao L; Shi X
Cancer Med; 2020 Jan; 9(1):141-150. PubMed ID: 31721465
[TBL] [Abstract][Full Text] [Related]
18. Relationship between tumor size and metastatic site in patients with stage IV non-small cell lung cancer: A large SEER-based study.
Shan Q; Fan Y; Guo J; Han X; Wang H; Wang Z
PeerJ; 2019; 7():e7822. PubMed ID: 31616594
[TBL] [Abstract][Full Text] [Related]
19. Metastasis pattern and prognosis of male breast cancer patients in US: a population-based study from SEER database.
Xie J; Ying YY; Xu B; Li Y; Zhang X; Li C
Ther Adv Med Oncol; 2019; 11():1758835919889003. PubMed ID: 31798694
[TBL] [Abstract][Full Text] [Related]
20. Population-based analysis of small cell carcinoma of the esophagus using the SEER database.
Li J; Ma J; Wang H; Niu J; Zhou L
J Thorac Dis; 2020 Jul; 12(7):3529-3538. PubMed ID: 32802432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
